prochlorperazine has been researched along with Breast Neoplasms in 12 studies
Prochlorperazine: A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612)
prochlorperazine : A member of the class of phenothiazines that is 10H-phenothiazine having a chloro substituent at the 2-position and a 3-(4-methylpiperazin-1-yl)propyl group at the N-10 position.
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this article is to assess the comparative antiemetic efficacy of prochlorperazine, ondansetron, and dexamethasone in the prevention of delayed chemotherapy-induced nausea and vomiting (CINV) after moderately high to highly emetogenic chemotherapy." | 9.11 | Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy: comparison of ondansetron, prochlorperazine, and dexamethasone. ( Amamoo, MA; Bernard, S; Goodin, S; Kane, M; Laliberte, K; Lindley, C; McCune, J; Pham, T; Schell, M; Shord, S; Socinski, MA; Yowell, S, 2005) |
| "The antiemetic effectiveness of haloperidol plus dexamethasone was compared with that of prochlorperazine plus dexamethasone in a prospective study of patients receiving chemotherapy for breast cancer." | 9.06 | A randomized comparison of haloperidol plus dexamethasone versus prochlorperazine plus dexamethasone in preventing nausea and vomiting in patients receiving chemotherapy for breast cancer. ( Carpenter, JT; Conolley, C; Lee, J; Silvey, L; Wheeler, RH, 1988) |
| "The purpose of this article is to assess the comparative antiemetic efficacy of prochlorperazine, ondansetron, and dexamethasone in the prevention of delayed chemotherapy-induced nausea and vomiting (CINV) after moderately high to highly emetogenic chemotherapy." | 5.11 | Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy: comparison of ondansetron, prochlorperazine, and dexamethasone. ( Amamoo, MA; Bernard, S; Goodin, S; Kane, M; Laliberte, K; Lindley, C; McCune, J; Pham, T; Schell, M; Shord, S; Socinski, MA; Yowell, S, 2005) |
| "The antiemetic effectiveness of haloperidol plus dexamethasone was compared with that of prochlorperazine plus dexamethasone in a prospective study of patients receiving chemotherapy for breast cancer." | 5.06 | A randomized comparison of haloperidol plus dexamethasone versus prochlorperazine plus dexamethasone in preventing nausea and vomiting in patients receiving chemotherapy for breast cancer. ( Carpenter, JT; Conolley, C; Lee, J; Silvey, L; Wheeler, RH, 1988) |
| "sensitive breast tumors were identified from three different publically available microarray datasets." | 1.37 | An integrated bioinformatics approach identifies elevated cyclin E2 expression and E2F activity as distinct features of tamoxifen resistant breast tumors. ( Dai, Y; Frasor, JM; Huang, L; Zhao, S, 2011) |
| "Nausea was assessed on a 1-7 scale four times a day for 4 days by diary." | 1.36 | Insight in the prediction of chemotherapy-induced nausea. ( Colagiuri, B; Colman, L; Heckler, CE; Hoelzer, K; Jacobs, A; Morrow, GR; Pudlo, BD; Roscoe, JA, 2010) |
| " The temporal and dose-response relationships suggested a possible association between the depressive symptoms and corticosteroid." | 1.36 | Suicide associated with corticosteroid use during chemotherapy: case report. ( Kinoshita, H; Matsumoto, Y; Shimizu, C; Shimizu, K; Uchitomi, Y, 2010) |
| "PONV is a significant problem in breast surgical patients." | 1.33 | Prevention of nausea and vomiting following breast surgery. ( Colvert, M; Henry-Tillman, RS; Kass, R; Klimberg, VS; Layeeque, R; Mancino, A; Siegel, E, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roscoe, JA | 1 |
| Morrow, GR | 1 |
| Colagiuri, B | 1 |
| Heckler, CE | 1 |
| Pudlo, BD | 1 |
| Colman, L | 1 |
| Hoelzer, K | 1 |
| Jacobs, A | 1 |
| Matsumoto, Y | 1 |
| Shimizu, K | 1 |
| Kinoshita, H | 1 |
| Shimizu, C | 1 |
| Uchitomi, Y | 1 |
| Huang, L | 1 |
| Zhao, S | 1 |
| Frasor, JM | 1 |
| Dai, Y | 1 |
| Sprung, J | 1 |
| Choudhry, FM | 1 |
| Hall, BA | 1 |
| Lindley, C | 1 |
| Goodin, S | 1 |
| McCune, J | 1 |
| Kane, M | 1 |
| Amamoo, MA | 1 |
| Shord, S | 1 |
| Pham, T | 1 |
| Yowell, S | 1 |
| Laliberte, K | 1 |
| Schell, M | 1 |
| Bernard, S | 1 |
| Socinski, MA | 1 |
| Layeeque, R | 1 |
| Siegel, E | 1 |
| Kass, R | 1 |
| Henry-Tillman, RS | 1 |
| Colvert, M | 1 |
| Mancino, A | 1 |
| Klimberg, VS | 1 |
| Trinkle, R | 1 |
| Garrido, SM | 1 |
| Chauncey, TR | 1 |
| Silvey, L | 1 |
| Carpenter, JT | 1 |
| Wheeler, RH | 1 |
| Lee, J | 1 |
| Conolley, C | 1 |
| Thorner, MO | 1 |
| Volans, G | 1 |
| Besser, GM | 1 |
| McNeilly, AS | 1 |
| Ward, HW | 1 |
2 trials available for prochlorperazine and Breast Neoplasms
| Article | Year |
|---|---|
Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy: comparison of ondansetron, prochlorperazine, and dexamethasone.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast | 2005 |
A randomized comparison of haloperidol plus dexamethasone versus prochlorperazine plus dexamethasone in preventing nausea and vomiting in patients receiving chemotherapy for breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclopho | 1988 |
10 other studies available for prochlorperazine and Breast Neoplasms
| Article | Year |
|---|---|
Insight in the prediction of chemotherapy-induced nausea.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast | 2010 |
Suicide associated with corticosteroid use during chemotherapy: case report.
Topics: Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents; Antiemetics; Antineoplastic Agents; Antineo | 2010 |
An integrated bioinformatics approach identifies elevated cyclin E2 expression and E2F activity as distinct features of tamoxifen resistant breast tumors.
Topics: Biological Phenomena; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Computational Biology; | 2011 |
Extrapyramidal reactions to ondansetron: cross-reactivity between ondansetron and prochlorperazine?
Topics: Adult; Antiemetics; Basal Ganglia Diseases; Breast Neoplasms; Cross Reactions; Female; Humans; Maste | 2003 |
Prevention of nausea and vomiting following breast surgery.
Topics: Administration, Oral; Administration, Rectal; Adult; Antiemetics; Breast Neoplasms; Cohort Studies; | 2006 |
Compatibility of hydromorphone and prochlorperazine, and irritation due to subcutaneous prochlorperazine infusion.
Topics: Analgesics, Opioid; Antiemetics; Breast Neoplasms; Drug Incompatibility; Female; Humans; Hydromorpho | 1997 |
Neuroleptic malignant syndrome following autologous peripheral blood stem cell transplantation.
Topics: Antipsychotic Agents; Breast Neoplasms; Droperidol; Female; Haloperidol; Hematopoietic Stem Cell Tra | 1998 |
Case problem: presenting conventional and complementary approaches for relieving nausea in a breast cancer patient undergoing chemotherapy.
Topics: Acupressure; Acupuncture Therapy; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols | 2000 |
Letter: Antiemetics, prolactin, and breast cancer.
Topics: Breast Neoplasms; Cyclizine; Humans; Nausea; Prochlorperazine; Prolactin | 1974 |
Letter: Metaclopramide and prolactin.
Topics: Breast Neoplasms; Humans; Metoclopramide; Prochlorperazine; Prolactin | 1974 |